Kauffman Michael
- SEC CIK
- 0001364719
Latest role at each company
- KYNB KYNTRA BIO, INC.Directoras of Jun 17, 2026
- CIK 0001645666Directoras of May 11, 2026
- VSTM Verastem, Inc.President of Developmentas of Jan 8, 2026
- ACET Adicet Bio, Inc.Directoras of Aug 23, 2024
- KPTI Karyopharm Therapeutics Inc.Directoras of Mar 2, 2022
Trades
Every Form 4 that lists Kauffman Michael as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| VSTMVerastem, Inc. | Nov 25, 2025 | Nov 21, 2025 | Kauffman MichaelDirector | SSaleCommon Stock | −8.55K | $10.00 | −$85.5K | 8.67K | −49.7% | SEC10b5-1 |
| ACETAdicet Bio, Inc. | Jun 7, 2024 | Jun 5, 2024 | Kauffman MichaelDirector | SSaleCommon Stock | −5.9K | $1.43 | −$8.44K | 5.9K | −50.0% | SEC |
| KPTIKaryopharm Therapeutics Inc. | Mar 2, 2022 | Feb 28, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −6.23K | $10.24 | −$63.75K | 713.76K | −0.9% | SEC |
| KPTIKaryopharm Therapeutics Inc. | Mar 2, 2022 | Feb 28, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −6.23K | $10.24 | −$63.75K | 898.13K | −0.7% | SEC |
| KPTIKaryopharm Therapeutics Inc. | Feb 22, 2022 | Feb 17, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −9.08K | $12.12 | −$110.04K | 698.98K | −1.3% | SEC |
| KPTIKaryopharm Therapeutics Inc. | Feb 22, 2022 | Feb 17, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −9.09K | $12.12 | −$110.15K | 904.36K | −1.0% | SEC |
| KPTIKaryopharm Therapeutics Inc. | Feb 9, 2022 | Feb 7, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −6.76K | $9.86 | −$66.69K | 708.06K | −0.9% | SEC |
| KPTIKaryopharm Therapeutics Inc. | Feb 9, 2022 | Feb 7, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −6.71K | $9.86 | −$66.13K | 913.45K | −0.7% | SEC |
| – | Jan 5, 2022 | Jan 3, 2022 | Kauffman MichaelDirector | SSaleCommon Stock | −5K | $16.45 | −$82.25K | 63.69K | −7.3% | SEC |